Skip to content

homoeopathic treatment of acid reflux

An open label (pre and post- homoeopathic intervention) study to evaluate efficacy of homoeopathic treatment of Non erosive gastro esophageal reflux disease - NEGERD

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/02/004426
Enrollment
30
Registered
2014-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Non erosive gastro-esophageal reflux disease

Interventions

Intervention1: Homoeopathic medicine: Individualized homoeopathic medicine for 56 days as per the need of the patient Control Intervention1: not applicable: not applicable

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ï?§ Patient presenting with heartburn & regurgitation with symptom score of more than 4 with normal endoscopic finding. ï?§ Patient having history of heart burn & regurgitation for 6 weeks with minimum of 2 episodes in a week.

Exclusion criteria

Exclusion criteria: ï?§ Pregnancy or lactation period. ï?§ Patients having: ï?¼ Dysphagia or associated alarm symptoms like gastrointestinal hemorrhage, mechanical obstruction or perforation. ï?¼ Peptic ulcer disease. ï?¼ Severe cardiac, pulmonary, hepatic or renal disease. ï?¼ Presence of gall stone disease. ï?§ Patient on concomitant medications known to affect the treatment response or recent h/o consumption of systemic glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs), Proton Pump Inhibitors and histamine 2-receptor antagonists within the previous 15 days. ï?§ Patients with history of previous surgery of gastrointestinal tract excluding appendectomy, cholecystectomy and polypectomy.

Design outcomes

Primary

MeasureTime frame
ï?§ Improvement in GERD -based symptom score from baseline to end of treatment. ï?§ Resolution of symptoms in terms of severity and frequency. ï?§ To assess the quality of life by WHO-QOL BREF. Timepoint: the outcome will be assessed at 56th week(at the end of treatment)

Secondary

MeasureTime frame
To deduce symptom of the drugs found effective.Timepoint: At the end of study

Countries

India

Contacts

Public ContactDr Anil Khurana

Central Council for Research in Homoeopathy

ccrhindia@gmail.com01128525749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026